169 related articles for article (PubMed ID: 37007129)
1. Adjuvant therapy for cholangiocarcinoma after surgery and prognosis factors for cholangiocarcinoma: A single-center retrospective cohort study.
Sun Z; Han X; You W; Tang J; Xu J; Ye B; Li T; Zhang Y; Chen K; Ding Y; Wang W
Front Oncol; 2023; 13():1116338. PubMed ID: 37007129
[TBL] [Abstract][Full Text] [Related]
2. Correlation Between Adjuvant Chemotherapy Regimen, Recurrence Pattern and Prognosis of Cholangiocarcinoma After Radical Surgery.
Rao L; Ma N; Liu Y; Du L; Qu B
Front Oncol; 2022; 12():695228. PubMed ID: 35223461
[TBL] [Abstract][Full Text] [Related]
3. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
[No Abstract] [Full Text] [Related]
4. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Serum Platelet-Lymphocyte Ratio as a Prognostic Factor in Cholangiocarcinoma Patients after Radical Resection: A Retrospective Analysis of 119 Patients.
Wu Y; Zhou D; Zhang G; Yi F; Feng L
Gastroenterol Res Pract; 2019; 2019():8506967. PubMed ID: 30809257
[TBL] [Abstract][Full Text] [Related]
6. Immune-related adverse events correlate with the efficacy of PD-1 inhibitors combination therapy in advanced cholangiocarcinoma patients: A retrospective cohort study.
Zhang Y; Wang X; Li Y; Hong Y; Zhao Q; Ye Z
Front Immunol; 2023; 14():1141148. PubMed ID: 37033935
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection.
Li XH; Zhao CY; Zhou EL; Lin XJ
BMC Cancer; 2022 Nov; 22(1):1159. PubMed ID: 36357848
[TBL] [Abstract][Full Text] [Related]
8. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
9. [Effect of postoperative adjuvant chemotherapy on prognosis of patients with intrahepatic cholangiocarcinoma:a multicenter retrospective study].
Lin QZ; Liu HZ; Zhou WP; Cheng ZJ; Lou JY; Zheng SG; Bi XY; Wang JM; Guo W; Li FY; Wang J; Zheng YM; Li JD; Cheng S; Zeng YY
Zhonghua Wai Ke Za Zhi; 2023 Feb; 61(4):305-312. PubMed ID: 36822587
[No Abstract] [Full Text] [Related]
10. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
Yang ZJ; Liu ZC; Wei RJ; Li L
Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
[TBL] [Abstract][Full Text] [Related]
11. Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor.
Yang H; Zhou J; Wei X; Wang F; Zhao H; Li E
Mol Clin Oncol; 2014 Nov; 2(6):1069-1075. PubMed ID: 25279199
[TBL] [Abstract][Full Text] [Related]
12. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
13. [The effect of prealbumin on the long-term prognosis of hilar cholangiocarcinoma following radical surgery].
Chen ZY; Liu ZP; Dai HS; Jiang Y; He Y
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):378-386. PubMed ID: 35272430
[No Abstract] [Full Text] [Related]
14. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors.
Wang Y; Zhu GQ; Zhou CW; Li N; Yang C; Zeng MS
Eur Radiol; 2022 Aug; 32(8):5166-5178. PubMed ID: 35316365
[TBL] [Abstract][Full Text] [Related]
16. Prognostic markers including immune and inflammatory factors predict outcomes in patients receiving postoperative radiation therapy for cholangiocarcinoma.
Mukai Y; Matsuyama R; Sugiura M; Yabushita Y; Taniuchi R; Homma Y; Hashimoto K; Miyake K; Tabuchi Y; Endo I; Hata M
Asia Pac J Clin Oncol; 2023 Feb; 19(1):226-233. PubMed ID: 35831998
[TBL] [Abstract][Full Text] [Related]
17. Natural History and Prognostic Factors of Cholangiocarcinoma With Spinal Metastasis: A 10-Year Single Center Study.
Sangsin A; Saiudom D; Pongmanee S; Saengsin J; Leerapun T; Murakami H
Clin Spine Surg; 2018 Apr; 31(3):E160-E165. PubMed ID: 29596214
[TBL] [Abstract][Full Text] [Related]
18. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
[No Abstract] [Full Text] [Related]
19. Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study.
Zhang G; Chen BW; Yang XB; Wang HY; Yang X; Xie FC; Chen XQ; Yu LX; Shi J; Lu YY; Zhao HT
World J Gastroenterol; 2022 Nov; 28(41):5968-5981. PubMed ID: 36405111
[TBL] [Abstract][Full Text] [Related]
20. Clinical correlation of cadherin-17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma.
Zheng BH; Shen S; Wong KF; Gong ZJ; Sun WT; Ni XJ; Wang JW; Hu MY; Liu H; Ni XL; Liu HB; Luk JM; Suo T
J Surg Oncol; 2021 Apr; 123(5):1253-1262. PubMed ID: 33524213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
